Cardiovascular–kidney–metabolic (CKM) syndrome represents a systemic disease continuum arising from the progressive and reciprocal interactions among metabolic dysfunction, kidney injury, and cardiovascular disease. Obesity and type 2 diabetes mellitus (T2DM) are major metabolic drivers of early CKM progression and con...
Feng-Zhao Liu, Zi-Han Xu, Wen-Ru Wang et al.· Frontiers in Cell and Develo...· 0 citations
BACKGROUND
Diabetic kidney disease (DKD) involves persistent tubular inflammation. Tetrandrine (Tet), a bioactive alkaloid from Stephania tetrandra S. Moore, has renoprotective potential, but its effects on TLR4-associated inflammatory signaling remain incompletely understood.
METHODS
Male KK-Ay mice received Tet (10...
Yan Yan, Wen-Ru Wang, Heng Chen et al.· International Immunopharmaco...· 0 citations
Diabetic kidney disease (DKD) is a leading cause of end-stage kidney disease (ESKD), and while current standard treatment strategies can slow disease progression, they are still unable to reverse progressive structural damage to the kidneys. Emerging evidence indicates that the senescence of renal tubular epithelial ce...
Jun-Wei Shi, Jia-Ning Sun, Jun-Wei Gao et al.· Frontiers in Cell and Develo...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.